Showing 1061-1070 of 9757 results for "".
A Guide to Building Lifelong Patient Loyalty
https://practicaldermatology.com/issues/october-2025/a-guide-to-building-lifelong-patient-loyalty/39758/Interest in medical aesthetic treatments continues to grow and signs indicate that demand will remain strong. Today’s patients are more informed and educated than ever and are seeking personalized, high-quality experiences.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuThe ESOP Model: An Alternative to PE for Dermatology Practices
https://practicaldermatology.com/issues/september-2025/the-esop-model-an-alternative-to-pe-for-dermatology-practices/37637/Not all practice models are as simple as private practice vs private equity. At Ada West Dermatology in Boise, Idaho, we’ve adopted a somewhat uncommon business model called an employee stock ownership plan (ESOP) and it’s worked very well for us.Dr. DiAnne Davis on Mentorship, Lasers, Skin of Color, and More
https://practicaldermatology.com/issues/september-2025/dr-dianne-davis-on-mentorship-lasers-skin-of-color-and-more/37643/In a recent YoungMD Connect virtual mentorship session, DiAnne Davis, MD, FAAD, a dermatologist based in Dallas, discussed her journey from patient to dermatologist, the influence of mentorship, and her commitment to advancing safe, effective cosmetic procedures for patients with skin of color.Access Is Everything
https://practicaldermatology.com/topics/practice-management/access-is-everything/23942/The Safe Step Act of 2023 seeks to rein in fail-first policies and protect patients.How May Biosimilars Affect the Treatment of Psoriasis?
https://practicaldermatology.com/topics/psoriasis/how-may-biosimilars-affect-the-treatment-of-psoriasis/23867/The answer depends on several factors.Spotlight on COVID-19 Related Hair Loss
https://practicaldermatology.com/topics/hair-nails/spotlight-on-covid-19-related-hair-loss/23667/CSF faculty members discuss COVID-19 related hair loss, its treatments, and its implicationsExamining the Emotional Impact of Acne in a Virtual World
https://practicaldermatology.com/columns/clinical-focus-1/examining-the-emotional-impact-of-acne-in-a-virtual-world/23577/Acne patients are working hard to conceal their acne on Zoom.Game On: Learning Gets Upgraded
https://practicaldermatology.com/topics/practice-management/game-on-learning-gets-upgraded/23544/Will gamification change the way dermatologists learn?Checkpoint Blockade for Advanced cSCC: Exploring Newer Options
https://practicaldermatology.com/topics/skin-cancer-photoprotection/checkpoint-blockade-for-advanced-cscc-exploring-newer-options/23487/Two newer systemic options on the market provide hope in the fight against advanced cutaneous squamous cell carcinoma.